A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 293, Issue 27, Pages 10707-10717
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2018-05-21
DOI
10.1074/jbc.ra117.001698
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular function of the novel α7β2 nicotinic receptor
- (2018) Beatriz E. Nielsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular function of α7 nicotinic receptors as drug targets
- (2017) Cecilia Bouzat et al. JOURNAL OF PHYSIOLOGY-LONDON
- α4β2 Nicotinic Acetylcholine Receptors
- (2016) Simone Mazzaferro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- X-ray structure of the human α4β2 nicotinic receptor
- (2016) Claudio L. Morales-Perez et al. NATURE
- Brain α7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO
- (2016) Shenyan Gu et al. NEURON
- Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective
- (2016) Natalia D. Andersen et al. NEUROPHARMACOLOGY
- Allosteric modulation of nicotinic acetylcholine receptors
- (2015) Anna Chatzidaki et al. BIOCHEMICAL PHARMACOLOGY
- CHRFAM7A: a human-specific α7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS
- (2015) Xitong Dang et al. FASEB JOURNAL
- Unknown
- (2015) Todd Costantini et al. MOLECULAR MEDICINE
- The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function
- (2015) Melissa L. Sinkus et al. NEUROPHARMACOLOGY
- Stoichiometry for α-bungarotoxin block of α7 acetylcholine receptors
- (2015) Corrie J. B. daCosta et al. Nature Communications
- The Duplicated α7 Subunits Assemble and Form Functional Nicotinic Receptors with the Full-length α7
- (2014) Ying Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CHRFAM7A, a human-specific and partially duplicated α 7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury
- (2014) Todd W. Costantini et al. JOURNAL OF LEUKOCYTE BIOLOGY
- X-ray structure of the mouse serotonin 5-HT3 receptor
- (2014) Ghérici Hassaine et al. NATURE
- Are nicotinic acetylcholine receptors coupled to G proteins?
- (2013) Nadine Kabbani et al. BIOESSAYS
- Stoichiometry for activation of neuronal 7 nicotinic receptors
- (2013) N. Andersen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stoichiometry for drug potentiation of a pentameric ion channel
- (2013) C. J. B. daCosta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structures of a pentameric ligand-gated ion channel provide a mechanism for activation
- (2013) L. Sauguet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- α7 Nicotinic acetylcholine receptors and their role in cognition
- (2012) Balázs Lendvai et al. BRAIN RESEARCH BULLETIN
- Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 sensory gating
- (2012) Rachel H Flomen et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- End-Plate Acetylcholine Receptor: Structure, Mechanism, Pharmacology, and Disease
- (2012) Steven M. Sine PHYSIOLOGICAL REVIEWS
- Structure and Pharmacology of Pentameric Receptor Channels: From Bacteria to Brain
- (2012) Pierre-Jean Corringer et al. STRUCTURE
- The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function
- (2011) Tanguy Araud et al. BIOCHEMICAL PHARMACOLOGY
- Two Neuronal Nicotinic Acetylcholine Receptors, α4β4 and α7, Show Differential Agonist Binding Modes
- (2011) Nyssa L. Puskar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-Channel and Structural Foundations of Neuronal 7 Acetylcholine Receptor Potentiation
- (2011) C. J. B. daCosta et al. JOURNAL OF NEUROSCIENCE
- Functional Relationships between Agonist Binding Sites and Coupling Regions of Homomeric Cys-Loop Receptors
- (2011) N. Andersen et al. JOURNAL OF NEUROSCIENCE
- Agonist activation of 7 nicotinic acetylcholine receptors via an allosteric transmembrane site
- (2011) J. K. Gill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Function of Partially Duplicated Human α7 Nicotinic Receptor SubunitCHRFAM7AGene
- (2010) Ana M. de Lucas-Cerrillo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS
- (2010) Roberta Benfante et al. JOURNAL OF NEUROIMMUNOLOGY
- A 2-base pair deletion polymorphism in the partial duplication of the α7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia
- (2009) Melissa L. Sinkus et al. BRAIN RESEARCH
- Number and Locations of Agonist Binding Sites Required to Activate Homomeric Cys-Loop Receptors
- (2009) D. Rayes et al. JOURNAL OF NEUROSCIENCE
- Structural Basis of Activation of Cys-Loop Receptors: the Extracellular–Transmembrane Interface as a Coupling Region
- (2009) Mariana Bartos et al. MOLECULAR NEUROBIOLOGY
- I-TASSER server for protein 3D structure prediction
- (2008) Yang Zhang BMC BIOINFORMATICS
- RIC-3: a nicotinic acetylcholine receptor chaperone
- (2008) N S Millar BRITISH JOURNAL OF PHARMACOLOGY
- The Interface between Extracellular and Transmembrane Domains of Homomeric Cys-Loop Receptors Governs Open-Channel Lifetime and Rate of Desensitization
- (2008) C. Bouzat et al. JOURNAL OF NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started